ARTICLE | Clinical News
APD403: Phase II started
November 4, 2013 8:00 AM UTC
Acacia began a double-blind, placebo-controlled, international Phase II trial to evaluate 3 doses of APD403 in about 315 cancer patients receiving highly emetogenic chemotherapy. ...